Sales Force Empowerment: Closed Doors and Opened Windows?
Today’s healthcare landscape is changing, though reps remain the primary means to deliver information. It is becoming more difficult for sales reps to overcome access restrictions placed on them. As access to physicians decline, what are the changes needed to enable commercial teams to successfully sell their products? What are the strategies and tools sales reps need to overcome these barriers and boost sales. Download your free copy today.
Specialty Pharma is moving at a fast pace and is expected to grow by 67% in 2015 and more than quadruple by 2020, accounting for about $402 billion a year in sales. Along with its great promise of rescuing traditional Pharma from the danger of the patent cliff, the specialty market also entails many challenges, such as reimbursement and changing marketing models, to name a few. This comprehensive guide allows you to recognize trends and drivers of Specialty Pharma; troubleshoot unique Specialty Pharma challenges; rethink your marketing and sales model to make the right commercial operations transition; and implement Specialty Pharma analytics and make sense of data.
In the pharma industry, analysts are constantly being approached by everyone in the company at the same time. The requests all appear to be urgent and must be addressed in a timely manner. In light of the amount of data being collected, how can you best utilize your analysts? In this whitepaper, we will indicate the seven tips that can be implemented to empower your pharma analysts to be proactive rather than reactive.
Taking Care of Business: Why Not to Overlook your Managed Markets Team
The business of marketing and selling drugs has changed. Gone are the days when the physician had complete freedom to write the drug of his choosing. When a viable generic option is unavailable, a complex decision and approval path begins.
While Sales Reps remain the vital link to the physician, the Account Managers are integral to the ultimate success of your drug.
Unfortunately, the Managed Markets team is often the last group to receive analytical support. Enabling them with the right solution, one that makes analyses automated and easy, allows them to focus on the important work of getting your drug in the best formulary position and achieve successful pull-through.
Moving from BI to Big Data Analytics in Pharma: Build It or Buy It?
Can you honestly say you are positive that building a Pharma data analytics solution in-house will deliver faster and better results than buying one? In Pharma, an outsourced, Big Data end-to-end analytics solution can really build the business case and lead to optimized sales and effective marketing spend. Don’t take our word for it, see for yourself! Download our “Moving from BI to Big Data Analytics in Pharma Build it or Buy it” free article now.
Tired of entering sales calls blindly? Pharmaceutical sales is a job that demands endless creativity and planning. Reps have an average of 2-3 minutes to convince doctors that their drug is the best on the market. In this free whitepaper, we’ve outlined the top 5 practices that can help reps plan sales calls more efficiently and effectively. Download it today and start preventing sales call blindness.
Pharma Collaboration – The Solution to Common Pharma Problems
In this published series of articles, discover how your organization can adopt tactics toward better relationships with your patients/customers and between sales and marketing, as well as view the significance that technology collaborations offer.
No Need to Call the Plumber: 5 Ways to Take Control of Your Sales Pipeline
Have you ever clogged up your kitchen sink and not known why? Did you grab the plunger or did you call an expensive plumber to resolve the emergency? Managing a sales pipeline, especially in the complex life sciences industry, can often leave you feeling like you’ve lost control and calling a plumber is the only answer. Download this free whitepaper to learn how you can properly manage your sales pipeline.
Why Your Successful Drug Launch Starts with Our New Application
Just in time for the holidays, we’re releasing our brand new drug launch application to bring you – more insights – better market view – faster! Thanks to the rise of global value growth for specialist and biologic products, traditional success predictors such as company size and reputation, funds or a valuable product- do not suffice in today’s competitive market of smaller, highly targeted drug launches. That’s why Verix has developed the new drug launch application, dedicated to optimize 3 crucial factors for a successful drug launch: TtM, precise positioning and performance during the first 6 months.
Data Disparities – A Thing of the Past: How to leverage an advanced analytics solution for better sales alignment
You’ve got data in your hands, but data discrepancies are rendering your sales teams less efficient. How can Pharma put data analytics to good use and get a holistic view of commercial operations effectiveness? Put the data your organization already has at its disposal into the hands of the sales force teams – in meaningful ways. With a real-time, holistic view of data, your data analytics solution will finally deliver on expectations.
See how to automatically prepare for your brand review meetings in just a few minutes. See how you can create your brand review once with Verix’s ‘Tell a Story’, and use the story presentation mode for the review.
How to Empower Your Managed Markets Team with Winning Analytics
With the ever growing managed care data available, management teams are left too often with over a dozen different spreadsheets to single out the right information to boost sales. In days of challenges like these, what happens when you win an account or get a formulatory status improvement? Mainly, how does your sales organization call on the right doctors and quickly capitalize on wins? In this free whitepaper learn how to quickly pinpoint top payers with preferred access, develop campaigns to reach them, analyze pull-through data and subsequently identify the best targets for the reps to call upon – all at the push of a button.
Dependency on Healthcare Aggregated Information Providers: The Complexity of Switching a 3rd Party Data Source
How complex is the shift from one 3rd party data source provider to the other and how dependent are you today on your existing solution? Mainly how painful – if at all – would it be to switch? Download this free article to debunk a few myths and check how Daiichi Sankyo transferred from IMS to Symphony Health painlessly and successfully.
The Affordable Care Act and the Pharmaceutical Industry: Trends and Perspectives
The Affordable Care Act was put into place to address the skyrocketing costs of health care in the US. But what does it mean for the pharmaceutical industry? In this whitepaper we aim to address the three major components of ACA that impact pharma and highlight strategies that can help your business take advantage of ACA. Download the whitepaper now to learn more.
Verix Intelligent Business Alerts (HotSpots) Technology
Do you struggle filtering through the noise of big data? Traditional BI solutions are accompanied by a host of problems such as the silo effect, sending out junk alerts, or simply not be aligned with the complexity of the data. Big Data can be great but ONLY if you can filter through the noise to get the info that really matters.In this free whitepaper, learn how Verix’s Intelligent Business Alerts (HotSpots) platform can provide your company with insightful analysis to significantly improve business performance.
Over the next five years, specialty drugs are expected to be the biggest drivers of branded drug spend growth, with investment projecting to increase 30%. Why is that? How can you leverage this trend? In this free white paper, we review industry trends, hurdles to entry, impact to commercialization strategies and analysis tips. Are you ready to make the move to specialty medicines? Download your free copy today.
How to Deal with Data Discrepancies: Pharma Analytics’ Biggest Challenge
It’s well known that one of the next challenges in Pharma is without a doubt fixing those data ‘black holes’ created by missing data and data inaccuracies. Ever since Big Data came into play, and thanks to data providers such as IMS etc., data flow today is unstoppable. But problems like multiple data sources and missing crucial information like patient ID’s, are literally keeping Pharma analysts up at night. Download this article to learn more on data discrepancies and its implications on Pharma companies.
Not On the Medication Alone: How Pharma Can Help Contain the Diabetes Epidemic
In the past years, Pharma companies have demonstrated exceptional leadership in innovation with new therapies that expand the benefits to patients and delivery systems to improve convenience and adherence, but here is the catch: Drugs don’t work on patients who don’t take them!
Log onto your performance dashboard to check out any threats or opportunities to your business that you should focus on. Zoom into your territories and check out their performance cross-referenced with their KPI’s.
Empowering the Patient: Pharma’s Changing Relationship with Its Customers
“The empowered patient is dead! Long live the expectant patient!” says Emma D’Arcy. Health hedonists, health deniers, cybercondriacs… It’s all about patient centricity these days and no doubt everyone in Pharma wants to provide a positive customer experience. But is it that simple?
In this overview, leading experts provide their insights on burning questions the industry wants answers to. From a cultural revolution penetrating Pharma with ‘selfies’ and social networks, to new technologies allowing smarter management of larger amounts of data and more complex analyses, it’s crystal clear that the face of the Big Data and Pharma markets is changing. Download this free Outlook to find out what the experts wish for the New Year and which mandatory “shakings” are required to get the market rolling.